Ad is loading...
ALLO
Price
$2.27
Change
-$0.19 (-7.72%)
Updated
Nov 15 closing price
101 days until earnings call
TVTX
Price
$17.72
Change
-$0.75 (-4.06%)
Updated
Nov 15 closing price
106 days until earnings call
Ad is loading...

ALLO vs TVTX

Header iconALLO vs TVTX Comparison
Open Charts ALLO vs TVTXBanner chart's image
Allogene Therapeutics
Price$2.27
Change-$0.19 (-7.72%)
Volume$3.09M
CapitalizationN/A
Travere Therapeutics
Price$17.72
Change-$0.75 (-4.06%)
Volume$1.47M
CapitalizationN/A
ALLO vs TVTX Comparison Chart
Loading...
ALLO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TVTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ALLO vs. TVTX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALLO is a Sell and TVTX is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (ALLO: $2.27 vs. TVTX: $17.72)
Brand notoriety: ALLO and TVTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALLO: 142% vs. TVTX: 74%
Market capitalization -- ALLO: $475.96M vs. TVTX: $1.54B
ALLO [@Biotechnology] is valued at $475.96M. TVTX’s [@Biotechnology] market capitalization is $1.54B. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALLO’s FA Score shows that 0 FA rating(s) are green whileTVTX’s FA Score has 0 green FA rating(s).

  • ALLO’s FA Score: 0 green, 5 red.
  • TVTX’s FA Score: 0 green, 5 red.
According to our system of comparison, TVTX is a better buy in the long-term than ALLO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALLO’s TA Score shows that 5 TA indicator(s) are bullish while TVTX’s TA Score has 3 bullish TA indicator(s).

  • ALLO’s TA Score: 5 bullish, 4 bearish.
  • TVTX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ALLO is a better buy in the short-term than TVTX.

Price Growth

ALLO (@Biotechnology) experienced а -26.30% price change this week, while TVTX (@Biotechnology) price change was -10.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

ALLO is expected to report earnings on Feb 26, 2025.

TVTX is expected to report earnings on Mar 03, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TVTX($1.54B) has a higher market cap than ALLO($476M). TVTX YTD gains are higher at: 97.108 vs. ALLO (-29.283). ALLO has higher annual earnings (EBITDA): -256.56M vs. TVTX (-296.56M). ALLO has more cash in the bank: 445M vs. TVTX (277M). ALLO has less debt than TVTX: ALLO (87M) vs TVTX (402M). TVTX has higher revenues than ALLO: TVTX (203M) vs ALLO (65K).
ALLOTVTXALLO / TVTX
Capitalization476M1.54B31%
EBITDA-256.56M-296.56M87%
Gain YTD-29.28397.108-30%
P/E RatioN/AN/A-
Revenue65K203M0%
Total Cash445M277M161%
Total Debt87M402M22%
FUNDAMENTALS RATINGS
ALLO vs TVTX: Fundamental Ratings
ALLO
TVTX
OUTLOOK RATING
1..100
6570
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
91
Overvalued
PROFIT vs RISK RATING
1..100
10073
SMR RATING
1..100
9599
PRICE GROWTH RATING
1..100
8035
P/E GROWTH RATING
1..100
10055
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TVTX's Valuation (91) in the Biotechnology industry is in the same range as ALLO (97). This means that TVTX’s stock grew similarly to ALLO’s over the last 12 months.

TVTX's Profit vs Risk Rating (73) in the Biotechnology industry is in the same range as ALLO (100). This means that TVTX’s stock grew similarly to ALLO’s over the last 12 months.

ALLO's SMR Rating (95) in the Biotechnology industry is in the same range as TVTX (99). This means that ALLO’s stock grew similarly to TVTX’s over the last 12 months.

TVTX's Price Growth Rating (35) in the Biotechnology industry is somewhat better than the same rating for ALLO (80). This means that TVTX’s stock grew somewhat faster than ALLO’s over the last 12 months.

TVTX's P/E Growth Rating (55) in the Biotechnology industry is somewhat better than the same rating for ALLO (100). This means that TVTX’s stock grew somewhat faster than ALLO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALLOTVTX
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
71%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
77%
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
80%
MACD
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 14 days ago
80%
Bullish Trend 10 days ago
79%
Declines
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
76%
Aroon
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
84%
View a ticker or compare two or three
Ad is loading...
ALLO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
TVTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IFTAX10.080.03
+0.30%
Voya International High Div Low Vol A
SGDIX52.82-0.12
-0.23%
Sprott Gold Equity Institutional
KNGYX12.84-0.05
-0.39%
Vest S&P500 Div Aristocrats Trgt IncY
JHEQX33.26-0.31
-0.92%
JPMorgan Hedged Equity I
ECTGX105.01-1.63
-1.53%
Eaton Vance Tx-Mgd Growth 1.1 C

ALLO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALLO has been loosely correlated with FATE. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ALLO jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALLO
1D Price
Change %
ALLO100%
-7.72%
FATE - ALLO
58%
Loosely correlated
-2.88%
NTLA - ALLO
56%
Loosely correlated
-7.61%
BEAM - ALLO
55%
Loosely correlated
-8.59%
CRSP - ALLO
54%
Loosely correlated
+0.85%
CRBU - ALLO
54%
Loosely correlated
-4.78%
More

TVTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TVTX has been loosely correlated with RLAY. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if TVTX jumps, then RLAY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TVTX
1D Price
Change %
TVTX100%
-4.06%
RLAY - TVTX
44%
Loosely correlated
-8.84%
RPTX - TVTX
38%
Loosely correlated
-4.31%
ALLO - TVTX
38%
Loosely correlated
-7.72%
XNCR - TVTX
38%
Loosely correlated
-1.83%
ERAS - TVTX
37%
Loosely correlated
-4.98%
More